Elisa Furfaro

1.3k total citations
27 papers, 824 citations indexed

About

Elisa Furfaro is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Elisa Furfaro has authored 27 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 19 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Elisa Furfaro's work include Antifungal resistance and susceptibility (22 papers), Fungal Infections and Studies (18 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Elisa Furfaro is often cited by papers focused on Antifungal resistance and susceptibility (22 papers), Fungal Infections and Studies (18 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Elisa Furfaro collaborates with scholars based in Italy, United States and Brazil. Elisa Furfaro's co-authors include Claudio Viscoli, Małgorzata Mikulska, Valerio Del Bono, Anna Maria Raiola, Andrea Bacigalupo, Daniele Roberto Giacobbe, Elio Castagnola, Alessandra Mularoni, Roberto Bandettini and Maura Faraci and has published in prestigious journals such as Blood, Journal of Antimicrobial Chemotherapy and Critical Care.

In The Last Decade

Elisa Furfaro

27 papers receiving 816 citations

Peers

Countries citing papers authored by Elisa Furfaro

Since Specialization

Citations

This map shows the geographic impact of Elisa Furfaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Furfaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Furfaro more than expected).

Fields of papers citing papers by Elisa Furfaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Furfaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Furfaro. The network helps show where Elisa Furfaro may publish in the future.

Co-authorship network of co-authors of Elisa Furfaro

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Furfaro. A scholar is included among the top collaborators of Elisa Furfaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Furfaro. Elisa Furfaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 2022 ·Clinical Microbiology and Infection ·Małgorzata Mikulska, Elisa Furfaro, Laura Magnasco, Giulia Codda, Daniele Roberto Giacobbe, Chiara Dentone, Antonio Vena, Anna Marchese, Matteo Bassetti	5
2	Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 2022 ·Mycoses ·Małgorzata Mikulska, Elisa Furfaro, Silvia Dettori, Daniele Roberto Giacobbe, Laura Magnasco, Chiara Dentone, Lorenzo Ball, Chiara Russo, Lucia Taramasso, Antonio Vena, Emanuele Angelucci, Paolo Pelosi, Matteo Bassetti	18
3	Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and Infection 2020 ·Biology of Blood and Marrow Transplantation ·Elisa Furfaro, Laura Ambra Nicolini, (unknown), Carmen Di Grazia, Anna Maria Raiola, Riccardo Varaldo, Fabio Ferrando, Gaia Barisione, Bianca Bruzzone, Emanuele Angelucci, Claudio Viscoli, Małgorzata Mikulska	11
4	Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan 2019 ·Medical Mycology ·Małgorzata Mikulska, Elisa Furfaro, Elena De Carolis, (unknown), (unknown), (unknown), Emanuela Zappulo, Anna Maria Raiola, Carmen Di Grazia, Valerio Del Bono, Giuseppe Cittadini, Emanuele Angelucci, Maurizio Sanguinetti, Claudio Viscoli	22
5	Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 2018 ·European Journal of Clinical Microbiology & Infectious Diseases ·Daniele Roberto Giacobbe, Alessio Signori, Mario Tumbarello, Riccardo Ungaro, Giovanni Sarteschi, Elisa Furfaro, Małgorzata Mikulska, Maurizio Sanguinetti, Brunella Posteraro, Angela Raffaella Losito, Gennaro De Pascale, Valerio Del Bono, Claudio Viscoli	14
6	Performance of serum (1,3)‐ß‐d‐glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 2018 ·Mycoses ·Elisa Furfaro, Daniele Roberto Giacobbe, Valerio Del Bono, Alessio Signori, Fabio Guolo, Paola Minetto, Marino Clavio, Filippo Ballerini, Marco Gobbi, Claudio Viscoli, Małgorzata Mikulska	10
7	Performance of 1,3‐β‐D‐glucan for diagnosing invasive fungal diseases in children 2017 ·Mycoses ·Carmelina Calitri, Ilaria Caviglia, Giuliana Cangemi, Elisa Furfaro, Roberto Bandettini, Francesca Fioredda, Loredana Amoroso, Maura Faraci, Francesco Maria Risso, Girolamo Mattioli, Andrea Moscatelli, Riccardo Haupt, Elio Castagnola	18
8	Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 2017 ·Critical Care ·(unknown), Daniele Roberto Giacobbe, Małgorzata Mikulska, Mario Tumbarello, Elisa Furfaro, (unknown), Angela Raffaella Losito, Alessio Mesini, Gennaro De Pascale, Anna Marchese, Marco Bruzzone, Paolo Pelosi, Michele Mussap, Alexandre Molin, Massimo Antonelli, Brunella Posteraro, Maurizio Sanguinetti, Claudio Viscoli, Valerio Del Bono	59
9	Lower sensitivity of serum (1,3)-β- d -glucan for the diagnosis of candidaemia due to Candida parapsilosis 2016 ·Clinical Microbiology and Infection ·Małgorzata Mikulska, Daniele Roberto Giacobbe, Elisa Furfaro, Alessio Mesini, Anna Marchese, Valerio Del Bono, Claudio Viscoli	33
10	Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 2015 ·Clinical Microbiology and Infection ·Daniele Roberto Giacobbe, (unknown), Paolo Bruzzi, Małgorzata Mikulska, Elisa Furfaro, Alessio Mesini, Paola Tatarelli, (unknown), Catherine M. Viscoli, Arnaldo Lopes Colombo, Valerio Del Bono	23
11	Bloodstream Infections Are an Improbable Cause of Positive Serum (1,3)-β-d-Glucan in Hematology Patients 2014 ·Clinical and Vaccine Immunology ·Elisa Furfaro, Małgorzata Mikulska, Valerio Del Bono, Fabio Guolo, Paola Minetto, Marco Gobbi, Anna Ghiso, Andrea Bacigalupo, Claudio Viscoli	12
12	Non-cultural methods for the diagnosis of invasive fungal disease 2014 ·Expert Review of Anti-infective Therapy ·Małgorzata Mikulska, Elisa Furfaro, Claudio Viscoli	24
13	Case Report of the Reliability 1,3-β-d-Glucan Monitoring during Treatment of Peritoneal Candidiasis in a Child Receiving Continuous Peritoneal Dialysis 2012 ·Clinical and Vaccine Immunology ·Francesca Ginocchio, Enrico Verrina, Elisa Furfaro, (unknown), Roberto Bandettini, Elio Castagnola	9
14	Galactomannan testing might be useful for early diagnosis of fusariosis 2012 ·Diagnostic Microbiology and Infectious Disease ·Małgorzata Mikulska, Elisa Furfaro, Valerio Del Bono, Francesca Gualandi, Anna Maria Raiola, M.P. Molinari, (unknown), Maurizio Sanguinetti, Brunella Posteraro, Andrea Bacigalupo, Claudio Viscoli	32
15	Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible for false-positive results of the galactomannan assay 2012 ·Journal of Antimicrobial Chemotherapy ·Małgorzata Mikulska, Elisa Furfaro, Valerio Del Bono, Anna Maria Raiola, S. Ratto, Andrea Bacigalupo, Claudio Viscoli	80
16	Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases 2012 ·Journal of Infection ·Spinello Antinori, Mario Corbellino, Luca Meroni, F. Resta, Salvatore Sollima, Massimo Tonolini, Anna Maria Tortorano, Laura Milazzo, Lorenzo Bello, Elisa Furfaro, Massimo Galli, Claudio Viscoli	64
17	Clinical Performance of the (1,3)-β- d -Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections 2011 ·Clinical and Vaccine Immunology ·Valerio Del Bono, Emanuele Delfino, Elisa Furfaro, Małgorzata Mikulska, Elena Nicco, Paolo Bruzzi, Alessandra Mularoni, Matteo Bassetti, Claudio Viscoli	48
18	Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation 2010 ·Clinical Microbiology and Infection ·Elio Castagnola, Elisa Furfaro, Ilaria Caviglia, Maria Licciardello, Maura Faraci, Francesca Fioredda, Paolo Tomà, Roberto Bandettini, (unknown), Claudio Viscoli	39
19	Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients 2009 ·Bone Marrow Transplantation ·Małgorzata Mikulska, Anna Maria Raiola, Benedetto Bruno, Elisa Furfaro, Maria Teresa Van Lint, Stefania Bregante, Adalberto Ibatici, Valerio Del Bono, Andrea Bacigalupo, Claudio Viscoli	108
20	Invasive mycoses in children receiving hemopoietic SCT 2008 ·Bone Marrow Transplantation ·Elio Castagnola, Maura Faraci, C. Moroni, Roberto Bandettini, Claudio Granata, Silvia Caruso, Francesca Bagnasco, Ilaria Caviglia, (unknown), Elisa Furfaro, (unknown), Valeria Fazio, Giuseppe Morreale, Edoardo Lanino, Riccardo Haupt, Giorgio Dini, Claudio Viscoli	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact